Added to YB: 2025-04-21
Pitch date: 2025-04-16
MURA [bullish]
Mural Oncology plc
-18.4%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.
Market Cap
$36.1M
Pitch Price
$2.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.21
P/E
-0.30
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Mural Oncology: Former Spin Turned Broken Biotech
MURA bullish: Biotech trading below liquidation value after discontinuing nemvaleukin trials, cutting 90% of workforce & exploring strategic alternatives. Recent announcement sent shares up 100%+ but still at discount to est. net liquidation value. Company hinted at potential acquisition/merger vs reverse merger. Momentum building for cash return.
Read full article (2 min)